Back to Northern Trust Corp. Northern Trust Corp.

KPTI

6 quarters

Position history for Northern Trust Corp.Northern Trust Corp.'s holdings in Karyopharm Therapeutics Inc.

Yes. Northern Trust holds 160,006 shares of KPTI (Karyopharm Therapeutics), worth $1.6M, as of its Q2 2026 13F filing. It increased the position from 38,556 shares in Q1 2026. Northern Trust has held KPTI in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$1.6M

Current Shares

160,006

Total Value Change

+$1.5M

Total Shares Change

+141,096

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
160,006
+315.0%
$1.6M0.0%$9.77
41
2026-Q1
Increased
38,556
+32.9%
$214,7570.0%$5.57
20
2025-Q4
Increased
29,023
+53.8%
$213,6100.0%$7.36
22
2025-Q3
Decreased
18,876
-0.2%
$123,4490.0%$6.54
0
2025-Q2
Unchanged
18,910
0.0%
$81,5020.0%$4.31
0
2025-Q1
New
18,910
-
$70,7240.0%$3.74
32

Other major holders of KPTI: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Goldman Sachs Group Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used